These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7740496)

  • 1. Localization of topically applied TFPI binding sites in an intimectomized microvessel.
    Ornberg RL; Deune EG; Ozbek MR; Wun TC; Khouri RK
    Thromb Haemost; 1995 Jan; 73(1):55-8. PubMed ID: 7740496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tissue factor pathway inhibitor improves free-flap survival in a model simulating free-flap errors.
    Ozbeck MR; Brown DM; Deune EG; Lantieri LA; Kania NM; Pasia EN; Cooley BC; Wun TC; Khouri RK
    J Reconstr Microsurg; 1995 May; 11(3):185-8. PubMed ID: 7650643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of tissue factor pathway inhibitor (TFPI) as topically applied antithrombotic agent.
    Aagaard S; Hjortdal VE; Barker JH
    APMIS Suppl; 2003; (109):102-7. PubMed ID: 12874959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor and its inhibition at the human microvascular anastomosis.
    Dumanian GA; Heil BV; Khouri RK; Hong C; Labadie K; Wun TC; Johnson PC
    J Surg Res; 1996 Jan; 60(1):263-9. PubMed ID: 8592425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma.
    Khouri RK; Koudsi B; Kaiding F; Ornberg RL; Wun TC
    Ann Plast Surg; 1993 May; 30(5):398-402; discussion 402-4. PubMed ID: 8342923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor.
    Stalboerger PG; Panetta CJ; Simari RD; Caplice NM
    Thromb Haemost; 2001 Sep; 86(3):923-8. PubMed ID: 11583328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
    Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
    J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topically applied tissue factor pathway inhibitor reduced intimal thickness of small arterial autografts in rabbits.
    Sun LB; Utoh J; Moriyama S; Tagami H; Okamoto K; Kitamura N
    J Vasc Surg; 2001 Jul; 34(1):151-5. PubMed ID: 11436089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
    Brodin E; Iversen N; Hansen JB
    J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor pathway inhibitor expression in atherosclerosis.
    Drew AF; Davenport P; Apostolopoulos J; Tipping PG
    Lab Invest; 1997 Oct; 77(4):291-8. PubMed ID: 9354763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of human tissue factor pathway inhibitor gene transfection on neointima formation in vein grafts].
    Li Q; Zhang K; Jiang X; Sun T; Wu L; Zhou C; Chen S
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):354-8. PubMed ID: 18396721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and expression of tissue factor pathway inhibitor by serum-stimulated fibroblasts, vascular smooth muscle cells and cardiac myocytes.
    Bajaj MS; Steer S; Kuppuswamy MN; Kisiel W; Bajaj SP
    Thromb Haemost; 1999 Dec; 82(6):1663-72. PubMed ID: 10613653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electromicroscopic observations on small vessels in animals treated with sulfinpyrazone and placebo following vascular microsurgery.
    Brunelli G; Vigasio A; Mukenge S; Verdecchia P
    Int Surg; 1982; 67(2):163-8. PubMed ID: 7118474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.
    Caplice NM; Panetta C; Peterson TE; Kleppe LS; Mueske CS; Kostner GM; Broze GJ; Simari RD
    Blood; 2001 Nov; 98(10):2980-7. PubMed ID: 11698280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor pathway inhibitor; its structure, function and clinical significance.
    Kato H
    Pol J Pharmacol; 1996; 48(1):67-72. PubMed ID: 9112630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis.
    Pan S; Kleppe LS; Witt TA; Mueske CS; Simari RD
    Thromb Haemost; 2004 Sep; 92(3):495-502. PubMed ID: 15351845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.